Accounts Payable, Current in USD of Cordyceps Sunshine Biotech Holdings Co., Ltd. from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Accounts Payable, Current history and change rate from Q4 2020 to Q4 2024.
  • Cordyceps Sunshine Biotech Holdings Co., Ltd. Accounts Payable, Current for the quarter ending 31 Dec 2024 was $276K, a 48.9% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Change (%)

Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Accounts Payable, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $276K +$90.7K +48.9% 31 Dec 2024 20-F 13 Jun 2025
Q4 2023 $185K -$566K -75.3% 31 Dec 2023 20-F/A 23 Sep 2025
Q4 2022 $751K +$639K +572% 31 Dec 2022 20-F 15 May 2023
Q4 2021 $112K +$112K 31 Dec 2021 20-F 15 May 2023
Q4 2020 $123* 31 Dec 2020 20-F 15 May 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.